Using a Difficult-to-treat Resistance Index to Gauge Imbalance between Countries’ Antibiotic Resistance Prevalence and Access to Antibiotics: A Scoping Review and Concept Proposal

  10 March 2025

The difficult-to-treat resistance (DTR) definition provides a global framework for assessing the impact of antimicrobial resistance on patient outcomes. A scoping review was conducted to understand the international adoption, scalability, and prognostic utility of DTR and to incorporate antibiotic access into the DTR framework. The study found that DTR was used in 57 studies across 94 countries, with 70% of them applying unmodified DTR definitions. The proposed DTRi could appraise the clinical impact of new agents, identify resistance-access imbalances, and optimize resource allocation to improve antibiotic resistance outcomes, particularly in under-resourced populations.

Author(s): Morgan K. Walker et al
Healthy Patients  
Back

OUR UNDERWRITERS

Unrestricted financial support by:

Antimicrobial Resistance Fighter Coalition

Bangalore Bioinnovation Centre

INTERNATIONAL FEDERATION PHARMACEUTICAL MANUFACTURERS & ASSOCIATIONS

BD





AMR NEWS

Your Biweekly Source for Global AMR Insights!

Stay informed with the essential newsletter that brings together all the latest One Health news on antimicrobial resistance. Delivered straight to your inbox every two weeks, AMR NEWS provides a curated selection of international insights, key publications, and the latest updates in the fight against AMR.

Don’t miss out on staying ahead in the global AMR movement—subscribe now!

Subscribe
What is going on with AMR?
Stay tuned with remarkable global AMR news and developments!